|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Mechanisms for Cell Growth & Differentiation | ||||||||||||||||
| June 21, 2001 | ||||||||||||||||
|
UT M. D. Anderson Cancer Center, JW Marriott Hotel, 5150 Westheimer, Houston, Texas October 2-5, 2001 Tuesday, October 2, 2001 4:00 p.m. Conference Registration 6:15 Welcome and Opening Remarks John Mendelsohn, M.D. 6:30 Introduction John Mendelsohn, M.D. Ernst W. Bertner Award Presentation and Lecture "Germ Line Modification" Ralph Brinster, V.M.D., Ph.D. 7:00 Introduction Margaret Kripke, Ph.D. Keynote Speaker "Why Germ Cells?" Ryuzo Yanagimachi, Ph.D. 8:00 Reception Wednesday, October 3, 2001 7:30 a.m. Conference Registration and Coffee 8:00 a.m. SESSION I - STEM CELL BIOLOGY Co-Chairs: Richard R. Behringer, Ph.D. and Margaret A. Goodell, Ph.D. 8:10 Overview Developmental Biology of Human ES Cells Roger A. Pedersen, Ph.D. 8:55 Gene Function and Regulation in Pluripotent Stem Cells and Germ Cells Hans R. Scholer, Ph.D. 9:25 Biology of Stem and Progenitor Cells Irving Weissman, M.D. 9:55 Break 10:25 Natural Stem Cells Urban Lendahl, Ph.D. 10:55 Adult Mesenchymal Stem Cells for Tissue Regeneration Mark F. Pittenger, Ph.D. 11:30 a.m. Lunch/Poster Session I 1:00 p.m. SESSION II - FUNCTIONAL GENOMICS Co-Chairs: Guillermina Lozano, Ph.D. and Howard Gutstein, M.D. 1:10 Overview Proteomics Keith Williams, Ph.D. 1:55 Genome-wide Definition of Protein Networks Mark Vidal, Ph.D. 2:25 Genomic Changes in Mouse Tumor Models Wei-Wen Cai, Ph.D. 2:55 Break 3:25 Mouse Mutagenesis: Defining Gene Function and Modeling Human Disease Monica Justice, Ph.D. 3:55 Introduction - Stephen P. Tomasovic, Ph.D. Wilson S. Stone Award 4:45-6:30 p.m. Poster Reception Thursday, October 4, 2001 7:30 a.m. Conference Registration and Coffee 8:00 a.m. SESSION III - SIGNALING PATHWAYS Co-Chairs: Mong-Hong Lee, Ph.D. and Yasuhide Furuta, Ph.D. 8:10 Overview Vertebrate Axis Formation Edward De Robertis, M.D., Ph.D. 8:55 Angiogenesis George D. Yancopoulos, M.D., Ph.D. 9:25 Notch Pathways Thomas Gridley, Ph.D. 9:55 Break 10:25 Protein Tyrosine Phosphatases Nicholas Tonks, Ph.D. 10:55 Hedgehog Signaling in Development and Disease Philip Beachy, Ph.D. 11:25 Rules Governing Human Cell Transformation Robert Weinberg, Ph.D. 12:00 p.m. Lunch/Poster Session II 1:30 p.m. SESSION IV - DIFFERENTIATION Co-Chairs: Randy Johnson, Ph.D. and Sophia Tsai, Ph.D. 1:40 Overview Genetic Control of Chondrocyte Differentiation Benoit de Crombrugghe, M.D. 2:25 Molecular Regulation of Cell Differentiation by SOX Transcription Factors Peter Koopman, Ph.D. 2:55 Met Signaling and the Control of Migration of Muscle Progenitors Carmen Birchmeier, Ph.D. 3:25 Break 3:55 Molecular Aspects of Blood Cell Development Stuart H. Orkin, M.D. 4:25 Muscle Differentiation Nadia Rosenthal, Ph.D. 4:55-6:30 p.m. Poster Reception Friday, October 5, 2001 7:30 a.m. Conference Registration and Coffee 8:00 a.m. SESSION V - PROLIFERATION AND APOPTOSIS Co-Chairs: Jill Schumacher, Ph.D. and Sharon Y. R. Dent, Ph.D. 8:10 Overview Cell Cycle Control in Normal and Tumor Cells James Roberts, M.D, Ph.D. 8:55 Trading Places at the Telomere: Recruitment of Multiple Complexes to the Chromosome Terminus Vicki Lundblad, Ph.D. 9:25 Break 9:55 Regulators of Cell Death in Drosophila Andreas Bergmann, Ph.D. 10:25 Wnt Signaling and Cancer Tetsuo Noda, M.D. 10:55 Mouse Models for p53 Mutation in Mammary Carcinogenesis Eva Lee, Ph.D. 11:30 Closing Remarks/Adjourn |
||||||||||||||||
| Organized by: | UT M. D. Anderson Cancer Center | |||||||||||||||
| Invited Speakers: | Philip Beachy, Ph.D. The Johns Hopkins School of Medicine Baltimore, Maryland Richard R. Behringer, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Andreas Bergmann, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Carmen Birchmeier, Ph.D. Max-Delbruck Centre for Molecular Medicine Berlin, Germany Ralph Brinster, V.M.D., Ph.D. University of Pennsylvania Philadelphia, Pennsylvania Wei-Wen Cai, Ph.D. Baylor College of Medicine Houston, Texas Benoit de Crombrugghe, M.D. UT M. D. Anderson Cancer Center Houston, Texas Edward De Robertis, M.D., Ph.D. University of California Los Angeles, California Sharon Y. R. Dent, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Yasuhide Furuta, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Margaret A. Goodell, Ph.D. Baylor College of Medicine Houston, Texas Thomas Gridley, Ph.D. Jackson Laboratory Bar Harbor, Maine Howard Gutstein, M.D. UT M. D. Anderson Cancer Center Houston, Texas Randy Johnson, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Monica Justice, Ph.D. Baylor College of Medicine Houston, Texas Peter Koopman, Ph.D. The University of Queensland Brisbane, Australia Eva Lee, Ph.D. University of Texas Health Science Center San Antonio, Texas Mong-Hong Lee, M.D. UT M. D. Anderson Cancer Center Houston, Texas Urban Lendahl, Ph.D. Karolinska Institute Stockholm, Sweden Guillermina Lozano, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Vicki Lundblad, Ph.D. Baylor College of Medicine Houston, Texas Tetsuo Noda, M.D. Japanese Foundation for Cancer Research Tokyo, Japan Stuart H. Orkin, M.D. Dana Farber Cancer Institute Boston, Massachusetts Roger A. Pedersen, Ph.D. University of California San Francisco, California Mark F. Pittenger, Ph.D. Osiris Therapeutics, Inc. Baltimore, Maryland James Roberts, M.D., Ph.D. Fred Hutchinson Cancer Center Seattle, Washington Nadia Rosenthal, Ph.D. Massachusetts General Hospital Charlestown, Massachusetts Hans R. Scholer, Ph.D. New Bolton Center University of Pennsylvania Philadelphia, Pennsylvania Jill Schumacher, Ph.D. UT M. D. Anderson Cancer Center Houston, Texas Nicholas Tonks, Ph.D. Cold Spring Harbor Laboratory Cold Spring Harbor, New York Sophia Tsai, Ph.D. Baylor College of Medicine Houston, Texas Mark Vidal, Ph.D. Harvard Medical School Charlestown, Massachusetts Robert Weinberg, Ph.D. Whitehead Institute Cambridge, Massachusetts Irving Weissman, M.D. Stanford University Stanford, California Keith Williams, Ph.D. Proteome Systems Sydney, Australia George D. Yancopoulos, M.D., Ph.D. Regeneron Pharmaceuticals, Inc. Tarrytown, New York Ryuzo Yanagimachi, Ph.D. University of Hawaii Honolulu, Hawaii |
|||||||||||||||
| Deadline for Abstracts: | July 15, 2001 | |||||||||||||||
| Registration: | On-site registration opens at 4:00 p.m, October 2, 2001. The opening session will begin at 6:30 p.m. on Tuesday evening, October 2 and the symposium will adjourn at 1:00 p.m. on Friday, October 5. Advance registration is encouraged as space and materials are limited and the deadline is September 21, 2001. To preregister, please complete the on-line registration form. MasterCard, VISA, and American Express are accepted for registration on-line or fax: (713) 794-1724. If you are paying by check (payable through U.S. banks only) or money order, print out the registration form and mail it to: 54th Research Symposium, Conference Services-HMB 131, UT M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009. Registration Fee Schedule: The full conference registration fee includes the tuition, abstract book, two lunches, breaks, and receptions. The student registration fee includes all of the above excluding lunches. Students wishing to participate in lunches must pay an additional fee of $35.00. Postmarked: By 9/21/01 After 9/21/01 Full conference fee $300 $375 One-day registration fee $105 $135 (Wednesday, Thursday, or Friday) M. D. Anderson Associates Members $225 $280 Student registration fee $100 $125 Student lunch fee $35 $40 Students: A reduced registration fee has been established for full-time students and physicians in training (interns, residents, and fellows). All students claiming this reduced fee are required to submit a letter of introduction from the chairperson of their department with their registration form. |
|||||||||||||||
| E-mail: | meetings@mdaisd1.tmc.edu | |||||||||||||||
| Posted by: | Pam Hamre | |||||||||||||||
| Host: | conf100.mdacc.tmc.edu | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||